Evidence map›Paper›PMID 27992403›Full record

ArticleNature immunology2017

Themis2 lowers the threshold for B cell activation during positive selection.

Daian Cheng, Mukta Deobagkar-Lele, Ekaterina Zvezdova, Seeyoung Choi, Shoji Uehara, Delphine Baup, Sophia C Bennett, Katherine R Bull, Tanya L Crockford, Helen Ferry and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Structural and Biochemical Analysis of the CABIT1 Domain of THEMIS.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. THEMIS increases TCR signaling in CD4Science signaling · 2023
    Article
  9. Article
  10. The Aging Human Lung Mucosa: A Proteomics Study.The journals of gerontology. Series A, Biological sciences and medical sciences · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. THEMIS: Two Models, Different Thresholds.Trends in immunology · 2017
    Review
  17. Themis2: setting the threshold for B-cell selection.Cellular & molecular immunology · 2017
    Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 4 countries.

Daian ChengMRC Human Immunology Unit, Weatherall Institute for Molecular Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Mukta Deobagkar-LeleMRC Human Immunology Unit, Weatherall Institute for Molecular Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Ekaterina ZvezdovaSection on Hematopoiesis and Lymphocyte Biology, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
Seeyoung ChoiSection on Hematopoiesis and Lymphocyte Biology, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
Shoji UeharaSection on Hematopoiesis and Lymphocyte Biology, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
Delphine BaupMRC Human Immunology Unit, Weatherall Institute for Molecular Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Sophia C BennettMRC Human Immunology Unit, Weatherall Institute for Molecular Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Katherine R BullMRC Human Immunology Unit, Weatherall Institute for Molecular Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Tanya L CrockfordMRC Human Immunology Unit, Weatherall Institute for Molecular Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Helen FerryMRC Human Immunology Unit, Weatherall Institute for Molecular Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Claude WarzechaSection on Hematopoiesis and Lymphocyte Biology, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
Marlène MarcellinInstitut de Pharmacologie et de Biologie Structurale and Université de Toulouse, Université Paul Sabatier, Centre National de la Recherche Scientifique, Toulouse, France.
Anne Gonzalez de PeredoInstitut de Pharmacologie et de Biologie Structurale and Université de Toulouse, Université Paul Sabatier, Centre National de la Recherche Scientifique, Toulouse, France.
Renaud LesourneCentre de Physiopathologie de Toulouse Purpan, Toulouse, France; and Institut National de la Santé et de la Recherche Médicale, U1043, Centre National de la Recherche Scientifique, and Université de Toulouse, Université Paul Sabatier, Toulouse, France.
Consuelo AnzilottiMRC Human Immunology Unit, Weatherall Institute for Molecular Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Paul E LoveSection on Hematopoiesis and Lymphocyte Biology, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
Richard J CornallMRC Human Immunology Unit, Weatherall Institute for Molecular Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
University of Oxford · GBNational Institutes of Health · USEunice Kennedy Shriver National Institute of Child Health and Human Development · USMRC Human Immunology Unit · GBUniversité Toulouse III - Paul Sabatier · FRCentre de Physiopathologie de Toulouse-Purpan · FR

Funding

Genes and signals controlling mammalian hematopoiesis.ZIAHD001803 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI LOVE, PAUL E · 2009 to 2025
$36.9M
Medical Research Council MC_UU_00008/6Medical Research Council MC_UU_12010/6NICHD NIH HHS ZIA HD001803Wellcome Trust
6 · The paper itself

Abstract

The positive and negative selection of lymphocytes by antigen is central to adaptive immunity and self-tolerance, yet how this is determined by different antigens is not completely understood. We found that thymocyte-selection-associated family member 2 (Themis2) increased the positive selection of B1 cells and germinal center B cells by self and foreign antigens. Themis2 lowered the threshold for B-cell activation by low-avidity, but not high-avidity, antigens. Themis2 constitutively bound the adaptor protein Grb2, src-kinase Lyn and signal transducer phospholipase γ2 (PLC-γ2), and increased activation of PLC-γ2 and its downstream pathways following B cell receptor stimulation. Our findings identify a unique function for Themis2 in differential signaling and provide insight into how B cells discriminate between antigens of different quantity and quality.

Indexed as

Clonal Selection, Antigen-MediatedLymphocyte ActivationAdaptive ImmunityAnimalsB-LymphocytesCell DifferentiationCell LineageCells, CulturedGerminal CenterGRB2 Adaptor ProteinIntracellular Signaling Peptides and ProteinsMiceMice, 129 StrainMice, Inbred C57BLMice, KnockoutMice, TransgenicGRB2 Adaptor ProteinGrb2 protein, mouseIntracellular Signaling Peptides and Proteinslyn protein-tyrosine kinasePhospholipase C gammaReceptors, Antigen, B-Cellsrc-Family KinasesThemis2 protein, mouse

Identifiers

PMID27992403
OpenAlexW2562541105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.